Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.96 |
| ▸ | MEN1 | O00255 | 2/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.92 |
| ▸ | ATM | Q13315 | 1/20 | 0.68 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.68 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.68 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27508518 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10494122 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL28152342 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534175 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| N-(Decanoyl)Pyrrolidine SCHEMBL10755236 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL151361 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| N-(Decanoyl)Pyrrolidine SCHEMBL692598 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10534171 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL10290341 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM | |
| SCHEMBL28149836 | 1.00 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| EP-2945604-B1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE SPECIFIC AMIDE COMPOUND | OREAL (FR) | 2019-04-10 | — | — | EP | disclosed |
| US-9993405-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound | L'OREAL (FR) | 2018-06-12 | — | — | US | disclosed |
| US-9993405-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one specific amide compound | L'OREAL (FR) | 2018-06-12 | — | — | US | disclosed |
| US-20150359718-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE SPECIFIC AMIDE COMPOUND | L'OREAL (FR) | 2015-12-17 | — | — | US | disclosed |
| US-20150359718-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE SPECIFIC AMIDE COMPOUND | L'OREAL (FR) | 2015-12-17 | — | — | US | disclosed |
| EP-2588506-B1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-07 | — | — | EP | disclosed |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | NOVO NORDISK HEALTHCARE AG (CH) | 2015-09-10 | — | — | US | disclosed |
| US-8993692-B2 | Self limiting catalyst composition for ethylene polymerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-03-31 | — | — | US | disclosed |
| WO-2014111570-A2 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE SPECIFIC AMIDE COMPOUND | L'OREAL (FR) | 2014-07-24 | — | — | WO | disclosed |
| US-20130131289-A1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-05-23 | — | — | US | disclosed |
| EP-2588506-A1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | Dow Global Technologies LLC (US) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012003219-A1 | SELF LIMITING CATALYST COMPOSITION FOR ETHYLENE POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-01-05 | — | — | WO | disclosed |
| WO-2009077844-A2 | INHIBITORS OF BIOFILM FORMATION OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA | QUONOVA LLC (US) | 2009-06-25 | — | — | WO | disclosed |
| US-4837026-A | Transdermal and systemic preparation and method | THERAPEUTIC PATCH RESEARCH N.V. | 1989-06-06 | — | — | US | disclosed |
| US-4716060-A | ACYCLIC OR HETEROCYCLIC TERTIARY AMIDE | RAJADHYAKSHA VITHAL J (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0240554-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA, Vithal J. (US) | 1987-10-14 | — | — | EP | disclosed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | disclosed |
| US-4171975-A | MAGENTA COUPLER AND AN AMIDE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150359718-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE SPECIFIC AMIDE COMPOUND | KRT18, CUTA, CRYZ | L3MBTL1 4739/4885MEN1 1077/4885KMT2A 804/4885 |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | L3MBTL1 4862/4885MEN1 4840/4885KMT2A 2718/4885 |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | GHRHR, GHSR, GHITM | L3MBTL1 4415/4885MEN1 2160/4885KMT2A 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.